
“We’re probably one of the only Venture Capital Trusts that has that 100% risk exposure to technology.” Meet Will Horlick of Molten Ventures, whose Venture Capital Trust (VCT) recently exited surgical device innovator Endomag. The portfolio also includes fintech ‘unicorn’ Thought Machine. What is the VCT’s investment approach in 2025? Has the challenging economic environment turned a corner? This 13-minute episode will tell you more…
For more details on Molten Ventures VCT, including documents & how to invest, see https://www.wealthclub.co.uk/y/molten-ventures-vct.
IMPORTANT
The opinions expressed in this video are the interviewee’s own and do not necessarily reflect the view of Wealth Club Limited. This interview, like our service, is not advice and the products featured are not suitable for everyone. Venture Capital Trusts are higher risk and less liquid than mainstream investments. You could get back less than you invest. Tax rules can change and tax benefits depend on your circumstances. If you’re unsure an investment is right for you, please seek professional advice.